Passage BIO, Inc. (PASG) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$49.30M | +30.0% |
| 2024 | -$70.40M | +35.0% |
| 2023 | -$108.39M | +21.7% |
| 2022 | -$138.39M | +25.5% |
| 2021 | -$185.73M | -64.5% |
| 2020 | -$112.90M | -203.6% |
| 2019 | -$37.19M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$49.30M | +30.0% |
| 2024 | -$70.40M | +35.0% |
| 2023 | -$108.39M | +21.7% |
| 2022 | -$138.39M | +25.5% |
| 2021 | -$185.73M | -64.5% |
| 2020 | -$112.90M | -203.6% |
| 2019 | -$37.19M | — |